Acupuncture for the pain of postherpetic neuralgia: A scoping review

Yang, Jiwei; Hu, Xiao-Yi; Xiu, Wen-Cui; Tian, Zhimei; Gang, Wei-Juan; Jing, Xiang-Hong

doi:10.1016/j.wjam.2022.04.001

Cited by 1 publication

(1 citation statement)

References 15 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…To identify the effect of KMT on PHN in detail, subgroup analysis was performed by dividing the groups according to the rash region and treatment sessions. Studies [59,60] on the status of PHN showed that the most common bodily region affected by rashes was the trunk, followed by the face. All patients included in our study had been affected on the trunk (8 patients, 62%) or face (5 patients, 38%).…”

Section: Discussionmentioning

confidence: 99%

Effect of Korean Medicine Treatment on Patients with Postherpetic Neuralgia: A Retrospective Chart Review

Jeon,

Lee,

Kim

et al. 2024

Healthcare

View full text Add to dashboard Cite

Evidence regarding Korean medicine treatment (KMT) for neuropathic pain is lacking. We aimed to identify the effects of integrative KMT in patients with postherpetic neuralgia (PHN). We retrospectively analyzed the electronic medical records of patients with PHN who received KMT at Kyung Hee University Korean Medicine Hospital between August 2021 and July 2022. We evaluated the effects of KMT—comprising acupuncture, pharmacopuncture, herbal medicine, cupping, and moxibustion—on pain intensity using the numerical rating scale (NRS), Short-Form McGill Pain Questionnaire (SF-MPQ), Hospital Anxiety and Depression Scale–Anxiety (HADS-A), Hospital Anxiety and Depression Scale–Depression (HADS-D), Daily Sleep Interference Scale (DSIS), Fatigue Severity Scale (FSS), and EuroQol-5D. Among 53 patients with PHN, 13 were included. The NRS score for worst pain over 1 week decreased from 6.54 ± 0.64 at baseline to 3.85 ± 0.63 at 8 weeks (41% reduction, p < 0.01), while that for average pain over 1 week decreased from 4.93 ± 0.67 at baseline to 3.08 ± 0.46 at 8 weeks (37% reduction, p < 0.01). From baseline to 8 weeks, there were significant reductions in the SF-MPQ, HADS-A, FSS, and EuroQol-5D scores. No adverse events were reported after KMT. Therefore, KMT may be an effective treatment option for patients with PHN.

show abstract

Section: Discussionmentioning

confidence: 99%